Back

Large-scale genomic surveillance reveals immunosuppression drives mutation dynamics in persistent SARS-CoV-2 infections

Khurana, M. P.; Katsiferis, A.; Scheidwasser, N.; Sloth, M. M. B.; Curran-Sebastian, J.; Morgenstern, C.; Tang, M.-H. E.; Fonager, J.; Rasmussen, M.; Stegger, M.; Whittaker, C.; The Danish COVID-19 Genome Consortium (DCGC), ; Lehmann, S.; Mortensen, L. H.; Jokelainen, P.; Kraemer, M. U. G.; Ferguson, N. M.; Ghafari, M.; Krause, T. G.; Duchene, D. A.; Bhatt, S.

2025-02-14 infectious diseases
10.1101/2025.02.10.25321987 medRxiv
Show abstract

Persistent SARS-CoV-2 infections have been hypothesized to play a key role in the emergence of variants of concern. However, the factors determining which individuals are at risk and their viral molecular signatures during infection remain poorly understood. Using the extensive COVID-19 surveillance database in Denmark, comprising over 700,000 genomes, we identified 303 persistent infections and, critically, linked them to health and sociodemographic data. Our analysis confirms the hypothesis that immunocompromised individuals are at the highest risk of experiencing persistent infections. Other disease groups associated with mortality, such as diabetes, showed no such associations. Among these persistent infections, the viral sequences exhibited signs of diversifying selection, with recurrent mutations linked to treatment resistance. Our findings suggest that immunosuppression plays a key role in the emergence of novelty in persistent infections.

Published in Nature Communications (predicted rank #2) · training set

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.